Fu, Yan ORCID: 0000-0002-4942-159X, Zou, Tiantian, Shen, Xiaotian, Nelson, Peter J., Li, Jiahui, Wu, Chao, Yang, Jimeng, Zheng, Yan, Bruns, Christiane, Zhao, Yue, Qin, Lunxiu and Dong, Qiongzhu (2021). Lipid metabolism in cancer progression and therapeutic strategies. MedComm, 2 (1). S. 27 - 60. HOBOKEN: WILEY. ISSN 2688-2663

Full text not available from this repository.

Abstract

Dysregulated lipid metabolism represents an important metabolic alteration in cancer. Fatty acids, cholesterol, and phospholipid are the three most prevalent lipids that act as energy producers, signaling molecules, and source material for the biogenesis of cell membranes. The enhanced synthesis, storage, and uptake of lipids contribute to cancer progression. The rewiring of lipid metabolism in cancer has been linked to the activation of oncogenic signaling pathways and cross talk with the tumor microenvironment. The resulting activity favors the survival and proliferation of tumor cells in the harsh conditions within the tumor. Lipid metabolism also plays a vital role in tumor immunogenicity via effects on the function of the noncancer cells within the tumor microenvironment, especially immune-associated cells. Targeting altered lipid metabolism pathways has shown potential as a promising anticancer therapy. Here, we review recent evidence implicating the contribution of lipid metabolic reprogramming in cancer to cancer progression, and discuss the molecular mechanisms underlying lipid metabolism rewiring in cancer, and potential therapeutic strategies directed toward lipid metabolism in cancer. This review sheds new light to fully understanding of the role of lipid metabolic reprogramming in the context of cancer and provides valuable clues on therapeutic strategies targeting lipid metabolism in cancer.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Fu, YanUNSPECIFIEDorcid.org/0000-0002-4942-159XUNSPECIFIED
Zou, TiantianUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Shen, XiaotianUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Nelson, Peter J.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Li, JiahuiUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wu, ChaoUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Yang, JimengUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Zheng, YanUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Bruns, ChristianeUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Zhao, YueUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Qin, LunxiuUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Dong, QiongzhuUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-587055
DOI: 10.1002/mco2.27
Journal or Publication Title: MedComm
Volume: 2
Number: 1
Page Range: S. 27 - 60
Date: 2021
Publisher: WILEY
Place of Publication: HOBOKEN
ISSN: 2688-2663
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
FATTY-ACID SYNTHASE; STEAROYL-COA-DESATURASE; ATP CITRATE LYASE; SPHINGOSINE KINASE 1; ELEMENT-BINDING PROTEINS; HUMAN COLORECTAL-CANCER; CD8(+) T-CELLS; PROSTATE-CANCER; BREAST-CANCER; PHOSPHOLIPASE-DMultiple languages
Medicine, Research & ExperimentalMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/58705

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item